Gut-Derived Protein-Bound Uremic Toxins
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of the fastest growing global causes of mortality. When glomerular filtration rate begins to fall, uremic toxins accumulate in the serum and significantly increase the risk of death from cardiovascular disease an...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/9/590 |
id |
doaj-355754d47245419eb27a2bbc75b33dd2 |
---|---|
record_format |
Article |
spelling |
doaj-355754d47245419eb27a2bbc75b33dd22020-11-25T03:06:06ZengMDPI AGToxins2072-66512020-09-011259059010.3390/toxins12090590Gut-Derived Protein-Bound Uremic ToxinsAmanda L. Graboski0Matthew R. Redinbo1Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599-7365, USADepartments of Chemistry, Biochemistry, Microbiology and Genomics, University of North Carolina, Chapel Hill, NC 27599-3290, USAChronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of the fastest growing global causes of mortality. When glomerular filtration rate begins to fall, uremic toxins accumulate in the serum and significantly increase the risk of death from cardiovascular disease and other causes. Several of the most harmful uremic toxins are produced by the gut microbiota. Furthermore, many such toxins are protein-bound and are therefore recalcitrant to removal by dialysis. We review the derivation and pathological mechanisms of gut-derived, protein-bound uremic toxins (PBUTs). We further outline the emerging relationship between kidney disease and gut dysbiosis, including the bacterial taxa altered, the regulation of microbial uremic toxin-producing genes, and their downstream physiological and neurological consequences. Finally, we discuss gut-targeted therapeutic strategies employed to reduce PBUTs. We conclude that targeting the gut microbiota is a promising approach for the treatment of CKD by blocking the serum accumulation of PBUTs that cannot be eliminated by dialysis.https://www.mdpi.com/2072-6651/12/9/590protein-bound uremic toxinsintestinal microbiotagut-kidney axis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amanda L. Graboski Matthew R. Redinbo |
spellingShingle |
Amanda L. Graboski Matthew R. Redinbo Gut-Derived Protein-Bound Uremic Toxins Toxins protein-bound uremic toxins intestinal microbiota gut-kidney axis |
author_facet |
Amanda L. Graboski Matthew R. Redinbo |
author_sort |
Amanda L. Graboski |
title |
Gut-Derived Protein-Bound Uremic Toxins |
title_short |
Gut-Derived Protein-Bound Uremic Toxins |
title_full |
Gut-Derived Protein-Bound Uremic Toxins |
title_fullStr |
Gut-Derived Protein-Bound Uremic Toxins |
title_full_unstemmed |
Gut-Derived Protein-Bound Uremic Toxins |
title_sort |
gut-derived protein-bound uremic toxins |
publisher |
MDPI AG |
series |
Toxins |
issn |
2072-6651 |
publishDate |
2020-09-01 |
description |
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of the fastest growing global causes of mortality. When glomerular filtration rate begins to fall, uremic toxins accumulate in the serum and significantly increase the risk of death from cardiovascular disease and other causes. Several of the most harmful uremic toxins are produced by the gut microbiota. Furthermore, many such toxins are protein-bound and are therefore recalcitrant to removal by dialysis. We review the derivation and pathological mechanisms of gut-derived, protein-bound uremic toxins (PBUTs). We further outline the emerging relationship between kidney disease and gut dysbiosis, including the bacterial taxa altered, the regulation of microbial uremic toxin-producing genes, and their downstream physiological and neurological consequences. Finally, we discuss gut-targeted therapeutic strategies employed to reduce PBUTs. We conclude that targeting the gut microbiota is a promising approach for the treatment of CKD by blocking the serum accumulation of PBUTs that cannot be eliminated by dialysis. |
topic |
protein-bound uremic toxins intestinal microbiota gut-kidney axis |
url |
https://www.mdpi.com/2072-6651/12/9/590 |
work_keys_str_mv |
AT amandalgraboski gutderivedproteinbounduremictoxins AT matthewrredinbo gutderivedproteinbounduremictoxins |
_version_ |
1724675451048165376 |